Key Record Dates
ClinicalTrials.gov Identifier: | NCT03817320 |
---|---|
Brief Title: | PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma |
First Submitted : | January 22, 2019 |
First Submitted that Met QC Criteria : | January 24, 2019 |
First Posted : | January 25, 2019 |
Last Update Submitted that Met QC Criteria : | August 11, 2022 |
Last Update Posted : | August 15, 2022 |